Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000972920 | SCV001120650 | benign | not provided | 2023-10-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000972920 | SCV001889636 | benign | not provided | 2021-04-20 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000972920 | SCV004699776 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | CACNA1G: BP4, BP7 |
Breakthrough Genomics, |
RCV000972920 | SCV005252245 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004543633 | SCV004766719 | likely benign | CACNA1G-related disorder | 2019-03-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |